Queen's Medical Center
Clinical trials sponsored by Queen's Medical Center, explained in plain language.
-
COVID drug trial halted early: did tocilizumab help?
Disease control TerminatedThis study tested whether tocilizumab, an anti-inflammatory drug, could help hospitalized adults with severe COVID-19. It aimed to compare the drug to a placebo in about 300 people, but was stopped early after enrolling only 20 participants. The main goal was to see if the drug i…
Phase: PHASE3 • Sponsor: Queen's Medical Center • Aim: Disease control
Last updated May 26, 2026 07:01 UTC
-
Hydroxychloroquine COVID trial halted after just 17 patients
Disease control TerminatedThis study aimed to see if hydroxychloroquine could help hospitalized COVID-19 patients recover faster. It planned to enroll 350 adults but was stopped early after only 17 joined. Participants received either hydroxychloroquine plus usual care or usual care alone for five days, a…
Phase: PHASE3 • Sponsor: Queen's Medical Center • Aim: Disease control
Last updated May 26, 2026 06:46 UTC